Upfront Docetaxel with LH-RH Antagonist for Metastatic Hormone Sensitive Prostate Cancer Considering Epithelial to Mesenchymal Transition

ISSN Print: 2160-5440
ISSN Online: 2160-5629
www.scirp.org/journal/oju
E-mail: oju@scirp.org

Citations

"Upfront Docetaxel with LH-RH Antagonist for Metastatic Hormone Sensitive Prostate Cancer Considering Epithelial to Mesenchymal Transition"
written by Teiichiro Aoyagi, Isao Kuroda, Go Nagao,
published by Open Journal of Urology, Vol.10 No.11, 2020

has been cited by the following article(s):

[1]	Castration-Synchronized Upfront Docetaxel for metastatic Hormone Sensitive Prostate Cancer considering Epithelial to Mesenchymal Transition
	Medical Research Archives, 2022